A humanized antibody for imaging immune checkpoint ligand PD-L1 expression in tumors

Antibodies targeting the PD-1/PD-L1 immune checkpoint lead to tumor regression and improved survival in several cancers. PD-L1 expression in tumors may be predictive of response to checkpoint blockade therapy. Because tissue samples might not always be available to guide therapy, we developed and ev...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatterjee, Samit, Lesniak, Wojciech G., Gabrielson, Matthew, Lisok, Ala, Wharram, Bryan, Sysa-Shah, Polina, Azad, Babak Behnam, Pomper, Martin G., Nimmagadda, Sridhar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891115/
https://www.ncbi.nlm.nih.gov/pubmed/26848870
http://dx.doi.org/10.18632/oncotarget.7143

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4891115/
https://www.ncbi.nlm.nih.gov/pubmed/26848870
http://dx.doi.org/10.18632/oncotarget.7143

Ejemplares similares